4//SEC Filing
Sarlis Nicholas J. 4
Accession 0001209191-18-020014
CIK 0001390478other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 7:57 PM ET
Size
6.0 KB
Accession
0001209191-18-020014
Insider Transaction Report
Form 4
Sarlis Nicholas J.
Chief Medical Officer and SVP
Transactions
- Award
Stock Option (Right to Buy)
2018-03-13+70,000→ 70,000 totalExercise: $5.24Exp: 2028-03-12→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]One-quarter (1/4) of the option shares will vest and became exercisable one year from the March 13, 2018 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.
Documents
Issuer
SELLAS Life Sciences Group, Inc.
CIK 0001390478
Entity typeother
Related Parties
1- filerCIK 0001724151
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 7:57 PM ET
- Size
- 6.0 KB